–
Статьи в журналах
-
- 2019 Safety efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study
- Reilmann R., McGarry A., Grachev I.D., Savola J.M., Illarioshkin S.N.
- в журнале Lancet Neurology, издательство The Lancet Publishing Group (United Kingdom), том 18, № 2, с. 165-176